Chemotherapy

[1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955

[2] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) : 91 - 97

[3] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [J]. BLOOD, 1996, 87 (05) : 1710 - 1717

[4] BURRIS HA, IN PRESS J CLIN ONCO

[5] Retinoid differentiation therapy in promyelocytic leukemia [J]. FASEB JOURNAL, 1996, 10 (09) : 1025 - 1030

[6] Current perspectives on camptothecins in cancer treatment [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (03) : 327 - 338

[7] Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2653 - 2665

[8] THE TAXOIDS - PACLITAXEL AND DOCETAXEL [J]. LANCET, 1994, 344 (8932) : 1267 - 1272

[9] PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2688 - 2699

[10] Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1442 - 1455

[1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955

[2] A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) : 91 - 97

[3] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [J]. BLOOD, 1996, 87 (05) : 1710 - 1717

[4] BURRIS HA, IN PRESS J CLIN ONCO

[5] Retinoid differentiation therapy in promyelocytic leukemia [J]. FASEB JOURNAL, 1996, 10 (09) : 1025 - 1030

[6] Current perspectives on camptothecins in cancer treatment [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (03) : 327 - 338

[7] Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2653 - 2665

[8] THE TAXOIDS - PACLITAXEL AND DOCETAXEL [J]. LANCET, 1994, 344 (8932) : 1267 - 1272

[9] PACLITAXEL BY 3-HOUR INFUSION IN COMBINATION WITH BOLUS DOXORUBICIN IN WOMEN WITH UNTREATED METASTATIC BREAST-CANCER - HIGH ANTITUMOR EFFICACY AND CARDIAC EFFECTS IN A DOSE-FINDING AND SEQUENCE-FINDING STUDY [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) : 2688 - 2699

[10] Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1442 - 1455